Live

Stocks are rallying as Trump eased fears over China tariffs and Powell. See the latest.

NasdaqGM - Nasdaq Real Time Price USD

Anteris Technologies Global Corp. (AVR)

4.4400

+0.9300

+(26.50%)

As of 12:58:39 PM EDT. Market Open.

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

MINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices, announces a significant milestone in our mission to restore heart valve patients to healthy function. Our first in class, biomimetic DurAVR® Transcatheter Heart Valve (THV) has now been used to treat over 100 patients worldw

GlobeNewswire 23 days ago

AVR
+26.50%
Anteris Reports One-Year Patient Outcomes for DurAVR® THV

New class, biomimetic TAVR demonstrates sustained hemodynamic performance to one-yearMINNEAPOLIS and BRISBANE, Australia, March 21, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced one-year results for patients treated with its proprietary, balloon expandable, DurAVR® T

GlobeNewswire last month

AVR
+26.50%
Anteris Reports 2024 Financial Results and Provides Corporate Update

EAGAN, Minn. and BRISBANE, Australia, March 12, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the full year ended December 31, 2024, and provided a corporate update. 2024 Full Year Highlights & Recent Developments Achieved a successful U.S. Initia

GlobeNewswire last month

AVR
+26.50%
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays

MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Anteris® Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a structural heart company developing DurAVR® THV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th Annual TD Cowen Healthcare Conference, and the Barclays 27th Annual Global Healthcare Conference. The details of each conference a

GlobeNewswire last month

AVR
+26.50%
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

BRISBANE, Australia & EAGAN, Minn., December 17, 2024--Anteris Technologies Global Corp. ("ATGC" or "Anteris") is pleased to announce the closing of its initial public offering of 14,800,000 shares of its common stock (the "Common Stock") in the U.S. at a price of $6.00 per share (the "Offering"). An additional 2,220,000 shares of Common Stock are issuable pursuant to the underwriters’ option to purchase additional shares of Common Stock from ATGC (the "Green Shoe"), if exercised in full. ATGC’s

Business Wire 4 months ago

AMEUF

AVR
+26.50%
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

BRISBANE, Australia & EAGAN, Minn., December 13, 2024--Anteris Technologies Global Corp. ("ATGC") today announced the pricing of its initial public offering of 14,800,000 shares of its common stock ("Common Stock") in the U.S. (the "Offering"), at an initial public offering price of $6.00 per share. The shares are expected to begin trading on the Nasdaq Global Market on December 13, 2024 under the ticker symbol "AVR." The Offering is expected to close on December 16, 2024, subject to customary c

Business Wire 4 months ago

AMEUF

AVR
+26.50%

Performance Overview

Return	AVR	S&P 500 (^GSPC)
YTD	-20.43%	-8.21%
1-Year	-26.00%	+6.47%
3-Year	-26.00%	+26.38%